Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve.
Blood Protein Analysis Enhances Diagnosis of Rare Diseases Beyond Genome Sequencing
Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité, and Genomics England have discovered that blood protein analysis can aid in diagnosing rare diseases that genome sequencing fails to identify. This advancement could lead to better healthcare solutions in Iran, where genetic diseases are prevalent.
👥 Key Players
📰 What Happened
Researchers have found that analyzing blood proteins can provide crucial information for diagnosing rare diseases that genome sequencing alone may miss. This discovery enhances the understanding of genetic variants and their impacts on health.
- Blood protein analysis can identify new disease-causing genes.
- This method complements genome sequencing for better diagnostic accuracy.
💡 Why It Matters
📚 Background
Rare diseases often go undiagnosed due to limitations in current genetic testing methods. Blood protein analysis offers a promising alternative for identifying these conditions.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%